Article detail · 2011
Strategies to manage retinoblastoma in developing countries
Journal
Pediatric Blood & CancerISSN 1545-5009
The ISSN points to another catalog journal; the name is from the YÖKSİS record.
- Year
- 2011
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Pediatric Blood & Cancer
- Catalog match (ISSN) Pediatric Blood and Cancer
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
OpenAlex · English
Survival of retinoblastoma is >90% in developed countries but there are significant differences with developing countries in stage at presentation, available treatment options, family compliance, and survival. In low-income countries (LICs), children present with advanced disease, and the reasons are socioeconomic and cultural. In middle-income countries (MICs), survival rates are better (>70%), but there is a high prevalence of microscopically disseminated extraocular disease. Programs for eye preservation have been developed, but toxicity-related mortality is higher. Although effective treatment of microscopically extraocular disease improved the outcome, worldwide survival will be increased only by earlier diagnosis and better treatment adherence.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
166 citations
OpenAlex cited_by_count (cache / database)
7 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Challenges and differences in external radiation therapy for retinoblastoma from standard techniques to new developments 2015
- Chemotherapy in Retinoblastoma: Current Approaches 2015
- Retinoblastomda Kemoterapi: Güncel Yaklaşımlar (Chemotherapy in Retinoblastoma: Current Approaches) 2015
- Chemotherapy in Retinoblastoma Current Approaches 2015
- A 20-year audit of retinoblastoma treatment outcomes 2020
- Intraocular retinoblastoma features and treatment outcomes according to patient age at initial presentation 2026
- Surgical treatment of huge orbital retinoblastoma under general anesthesia in a three-year old child 2022